Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?
Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?
复制标题
VEGF/VEGFR与免疫细胞和癌细胞的关系:蹒跚还是向前?
DOI:
10.20892/j.issn.2095-3941.2015.0070
复制
发表时间:
2016-06
影响因子:
5.5
通讯作者:
Ren XB
中科院分区:
文献类型:
--
作者:
Li YL;Zhao H;Ren XB
Vascular endothelial growth factor (VEGF) is primarily known as a proangiogenic factor and is one of the most important growth and survival factors affecting the vascular endothelium. However, recent studies have shown that VEGF also plays a vital role in the immune environment. In addition to the traditional growth factor role of VEGF and VEGF receptors (VEGFRs), they have a complicated relationship with various immune cells. VEGF also reportedly inhibits the differentiation and function of immune cells during hematopoiesis. Dendritic cells (DCs), macrophages, and lymphocytes further express certain types of VEGF receptors. VEGF can be secreted as well by tumor cells through the autocrine pathway and can stimulate the function of cancer stemness. This review will provide a paradigm shift in our understanding of the role of VEGF/VEGFR signaling in the immune and cancer environment.